LisaMFormanMD

Gastroenterology • Aurora, CO

Hepatology & Liver Transplantation

Associate Professor, Medicine, University of Colorado School of Medicine

Join to view full profile

Dr. Forman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Forman's full profile

Already have an account?

Office
12605 E 16th Ave
Aurora, CO 80045
Phone+1 720-848-0000

Education & Training

University of Pennsylvania Health SystemFellowship, Gastroenterology, 1995 - 2001
University of Pennsylvania Health SystemResidency, Internal Medicine, 1995 - 1998
Perelman School of Medicine at the University of PennsylvaniaClass of 1995

Certifications & Licensure

NM State Medical License 2020 - 2027
CO State Medical License 2002 - 2025
WY State Medical License 2022 - 2025
PA State Medical License 1996 - 2002
American Board of Internal Medicine Transplant Hepatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACP) American College of Physicians, 2007

Clinical Trials

Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy Start of enrollment: 2013 Apr 03
Terminated
Phase 4

Publications & Presentations

PubMed

88 citations
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.
Christopher L Bowlus, Lionel Arrivé, Annika Bergquist, Mark Deneau, Lisa Forman
Hepatology. 2023-02-01
22 citations
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein, Kris V Kowdley, John M Vierling
Hepatology. 2023-08-01
70 citations
Hepatitis C virus–infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men†‡
Jennifer C. Lai, Elizabeth C. Verna, Robert S. Brown, Jacqueline G. O'Leary, James F. Trotter
Hepatology. 2011-08-01

Journal Articles

Pro: Steroids Can Be Withdrawn Posttransplant in Recipients with Autoimmune Hepatitis
Avash Kalra, James R Burton, Lisa Forman, Liver transplantation

Press Mentions

Champions for Their Patients: 21 Inducted into CU Department of Medicine’s New Clinical Excellence SocietyFebruary 29th, 2024

Professional Memberships

American College of Physicians - ACP
Fellow